JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


First published online September 14, 2007, 10.2967/jnumed.107.042317
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jnumed.107.042317v1
48/10/1633    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in JNM
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cosgrove, K. P.
Right arrow Articles by Staley, J. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cosgrove, K. P.
Right arrow Articles by Staley, J. K.
Journal of Nuclear Medicine Vol. 48 No. 10 1633-1640
© 2007 by Society of Nuclear Medicine

doi: 10.2967/jnumed.107.042317

Clinical Investigation

123I-5-IA-85380 SPECT Imaging of Nicotinic Acetylcholine Receptor Availability in Nonsmokers: Effects of Sex and Menstrual Phase

Kelly P. Cosgrove1,2, Effie M. Mitsis1,2, Frederic Bois1,2, Erin Frohlich1,2, Gilles D. Tamagnan1,3, Erica Krantzler1,2, Edward Perry1,2, Paul K. Maciejewski1, C. Neill Epperson1, Sharon Allen4, Stephanie O'Malley1, Carolyn M. Mazure1, John P. Seibyl3, Christopher H. van Dyck1 and Julie K. Staley1,2

1 Yale University School of Medicine, New Haven, Connecticut; 2 Veterans Affairs Connecticut Healthcare System, West Haven, Connecticut; 3 Institute for Neurodegenerative Disorders, New Haven, Connecticut; and 4 University of Minnesota, Minneapolis, Minnesota

Correspondence: For correspondence or reprints contact: Kelly P. Cosgrove, PhD, Yale University School of Medicine and the VACHS, Department of Psychiatry/116A6, 950 Campbell Ave., West Haven, CT 06516. E-mail: kelly.cosgrove{at}yale.edu

The study of the effects of sex and hormones on brain chemistry and neurotransmission is of increasing importance as evidence emerges of sex differences in behavioral symptoms and treatment response in neuropsychiatric disorders. The nicotinic acetylcholine receptor (nAChR) system has been implicated in a variety of psychiatric disorders, including tobacco smoking, for which there is strong evidence supporting sex differences in behaviors and response to smoking cessation treatments. We examined the availability of nAChR containing the ß2 subunit in healthy men and women and the influence of menstrual phase among women. Methods: Ten men and 19 women nonsmokers underwent one 123I-5-IA-85380 (123I-5-IA) SPECT scan and one MRI scan. A subset of 9 women, aged 18–39 y, underwent a second 123I-5-IA scan. These 9 women were scanned during the early follicular (days 4–7 in 8 subjects and day 11 in 1 subject) and mid-luteal (days 19–25) phases of their menstrual cycle. Hormone levels were measured in all women to confirm the phase of the cycle. Results: Regional brain activity (kBq/cm3) was higher (39%–54%) in women than in men nonsmokers. When regional brain activity was normalized to total plasma parent to correct for individual differences in radiotracer metabolism (VT'), differences of 10%–16% were observed, with women greater than men. In contrast, when regional brain activity was normalized to free plasma parent (VT), there was less than a 4% difference by sex in regional brain ß2-nAChR availability. These sex differences in kBq/cm3 and VT' resulted from significantly higher levels of total plasma parent, free fraction (f1), and free plasma parent in women than in men nonsmokers. No differences in plasma measures or brain ß2-nAChR availability were observed across the menstrual cycle for any outcome measure. Conclusion: Overall, these findings demonstrate no significant difference in brain ß2-nAChR availability between men and women nonsmokers or across the menstrual cycle. Importantly, these findings demonstrate sex differences in radiotracer metabolism and plasma protein binding and highlight the critical need to measure plasma radiotracer levels and f1 in studies that include both sexes.

Key Words: nicotinic • 123I-5-IA-85380 • free fraction • sex • menstrual cycle • SPECT

COPYRIGHT © 2007 by the Society of Nuclear Medicine, Inc.


Related articles in JNM:

This Month in JNM

JNM 2007 48: 11A-12A. [Full Text]  






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2007 by the Society of Nuclear Medicine.